Ignite Creation Date:
2025-12-25 @ 2:44 AM
Ignite Modification Date:
2026-02-05 @ 9:02 PM
Study NCT ID:
NCT03953833
Status:
COMPLETED
Last Update Posted:
2023-09-14
First Post:
2019-04-25
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
B003 in Patients With HER2-positive Recurrent or Metastatic Breast Cancer
Sponsor:
Shanghai Pharmaceuticals Holding Co., Ltd
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | HER2-positive Breast Cancer | View |